デフォルト表紙
市場調査レポート
商品コード
1159431

経鼻ドラッグデリバリーの世界市場(2022年~2028年)

Nasal Drug Delivery Market 2022-2028

出版日: | 発行: Orion Market Research | ページ情報: 英文 140 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
経鼻ドラッグデリバリーの世界市場(2022年~2028年)
出版日: 2022年10月21日
発行: Orion Market Research
ページ情報: 英文 140 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経鼻ドラッグデリバリーの市場規模は、予測期間中に5.5%のCAGRで成長すると予測されています。当市場を牽引する主な要因には、喘息と慢性閉塞性肺疾患(COPD)の有病率の上昇などがあります。

当レポートでは、世界の経鼻ドラッグデリバリー市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、セグメント別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 3M Co.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • APTARGROUP, INC.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • AstraZeneca
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Becton, Dickinson and Co.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Merck KGaA
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析
  • COVID-19が主要企業に与える影響

第4章 市場セグメンテーション

  • 剤形別
    • ゲル
    • スプレー
    • 滴と液体
    • その他(粉末)
  • 容器別
    • 非加圧容器
    • 加圧容器
  • 治療用途別
    • 鼻炎
    • 鼻詰まり
    • 喘息
    • その他(予防接種)
  • エンドユーザー別
    • 病院
    • 在宅医療

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Consort Medical plc
  • DTR Medical Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlaxoSmithKline plc.
  • GoFire, Inc
  • Herantis Pharma Plc
  • Hikma Pharmaceuticals PLC
  • H&T Presspart Manufacturing Ltd.
  • Johnson & Johnson Services, Inc.
  • Nanoform Finland Oyj
  • Nemera Services
  • Neurelis, Inc.
  • Novartis International AG
  • Olympus Corp.
  • Pfizer Inc.
  • Premier Inc.
  • Sanofi S.A
  • Summit Medical LLC
  • Teleflex Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group Ltd
図表

LIST OF TABLES

  • 1. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 2. GLOBAL GELS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL SPRAY NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

4. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

5. GLOBAL OTHERS NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 6. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 7. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 10. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 22. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 23. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 24. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 25. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 26. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 29. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 30. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 31. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2021-2028 ($ MILLION)
  • 34. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 35. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION,2021-2028 ($ MILLION)
  • 36. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 (%)
  • 4. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY DOSAGE FORM, 2021 VS 2028 (%)
  • 5. GLOBAL GELS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL SPRAYS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL OTHERS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
  • 10. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
  • 11. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY THERAPEUTIC APPLICATION, 2021 VS 2028 (%)
  • 13. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 18. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2026602

Global Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers), by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2022-2028)

The global nasal drug delivery market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period. The rising prevalence of Asthma and chronic obstructive pulmonary disease (COPD) are factors that are driving the market growth. Increasing patients pool of asthma and COPD across the globe are factors that increase the demand for nasal drugs for the treatment of diseases in the market. For instance, the report published by the Asthma and Allergy Foundation of America (AAFA), in May 2021, stated that approximately 25 million people alone in the US are suffering from asthma that is equal to 1 in 13 people aged 18 and older are living with asthma. Asthma rates are highest in black adults in the US in comparison with white adults.

The nasal drug delivery is segmented on the basis of dosage form, containers, therapeutic application, and end-user. Based on dosage form, the market is segmented into gels, sprays, drops and liquids, and others. On the basis of containers, the market is sub-divided into non-pressurized containers and pressurized containers. On the basis of therapeutic application, the market is sub-divided rhinitis, nasal congestion, asthma, and others. Furthermore, based on end-user, the market is sub-classified into hospitals and home health care. Among the end-user segment hospital segments are holding a prominent share owing to an increased number of patients pool administered in hospitals for the treatment of various diseases such as asthma, COPD, and others.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds a prominent share in the market owing to the increasing prevalence of asthma and chronic obstructive pulmonary disease and the rising adoption of technology-based treatment at procedures at an early stage. Furthermore, several technological advancements and growing product launches and innovations by key industry players in the market. For instance, in April 2019, Aptar Pharma, a new Bidose nasal spray device was approved by the US Food Drug Administration (FDA), for breakthrough therapy in the field of depression. This new Bidose liquid system intuitive and easy-to-use device with 360° functionality and precise spray characteristics and provides two-shot nasal drug delivery. Moreover, the growing number of individuals affected with asthma is such factor that is contributing to the North American region's market growth.

The competitive landscape includes key strategies of leading players, recent developments, and key company analysis. The major players that contribute to the growth of the market include 3M Co., APTARGROUP INC., AstraZeneca, Becton Dickinson and Co., Johnson & Johnson Service Inc., Merck KGaA, Novartis International AG, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2021, Nanoform Finland Plc and Herantis Pharma Plc entered into an agreement for the formulation of Proof of Concept projects (PoCs) that aims to enhance nasal drug delivery to the brain. Both the companies in collaboration stated to develop a formulation that increases penetration into the brain via the nasal drug delivery route for CDNF.

Research Methodology

The market study of the global nasal drug delivery market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Nasal Drug Delivery Market Research And Analysis By Dosage Form

2. Global Nasal Drug Delivery Market Research And Analysis By Containers

3. Global Nasal Drug Delivery Market Research and Analysis by Therapeutic Application

4. Global Nasal Drug Delivery Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodology of the global nasal drug delivery market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nasal drug delivery market.
  • Insights about market determinants that are stimulating the global nasal drug delivery market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Nasal Drug Delivery Market
  • Recovery Scenario of Global Nasal Drug Delivery Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. 3M Co.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. APTARGROUP, INC.,
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. AstraZeneca
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Becton, Dickinson and Co.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Merck KGaA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Nasal Drug Delivery Market by Dosage Form
    • 4.1.1. Gels
    • 4.1.2. Sprays
    • 4.1.3. Drops and Liquids
    • 4.1.4. Other (Powders)
  • 4.2. Global Nasal Drug Delivery Market by Containers
    • 4.2.1. Non-Pressurized Containers
    • 4.2.2. Pressurized Containers
  • 4.3. Global Nasal Drug Delivery Market by Therapeutic Application
    • 4.3.1. Rhinitis
    • 4.3.2. Nasal Congestion
    • 4.3.3. Asthma
    • 4.3.4. Others (Vaccination)
  • 4.4. Global Nasal Drug Delivery Market by End-User
    • 4.4.1. Hospitals
    • 4.4.2. Home Health Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Consort Medical plc
  • 6.2. DTR Medical Ltd.
  • 6.3. Glenmark Pharmaceuticals Ltd.
  • 6.4. GlaxoSmithKline plc.
  • 6.5. GoFire, Inc
  • 6.6. Herantis Pharma Plc
  • 6.7. Hikma Pharmaceuticals PLC
  • 6.8. H&T Presspart Manufacturing Ltd.
  • 6.9. Johnson & Johnson Services, Inc.
  • 6.10. Nanoform Finland Oyj
  • 6.11. Nemera Services
  • 6.12. Neurelis, Inc.
  • 6.13. Novartis International AG
  • 6.14. Olympus Corp.
  • 6.15. Pfizer Inc.
  • 6.16. Premier Inc.
  • 6.17. Sanofi S.A
  • 6.18. Summit Medical LLC
  • 6.19. Teleflex Inc.
  • 6.20. Teva Pharmaceutical Industries Ltd.
  • 6.21. Vectura Group Ltd